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Abstract
In the context of skeletal tissue development and repair, 
endochondral ossification has inspired a new approach to 
regenerate bone tissue in vivo using a cartilage intermediate 
as an osteoinductive template. The aim of this study was 
to investigate the behavior of mesenchymal stem cells 
(MSCs) in regard to in vitro cartilage formation and in vivo 
bone regeneration when combined with different three-
dimensional (3D) scaffold materials, i.e., hydroxyapatite/
tricalcium phosphate (HA/TCP) composite block, 
polyurethane (PU) foam, poly(lactic-co-glycolic acid)/
poly(ε-caprolactone) electrospun fibers (PLGA/PCL) and 
collagen I gel. To this end, rat MSCs were seeded on these 
scaffolds and chondrogenically differentiated in vitro for 4 
weeks followed by in vivo subcutaneous implantation for 
8 weeks. After in vitro chondrogenic priming, comparable 
cell amounts and cartilage formation were observed in all 
types of scaffolds. Nonetheless, the quality and maturity 
of in vivo ectopic bone formation appeared to be scaffold/
material-dependent. Eight weeks of implantation was not 
sufficient to ossify the entire PLGA/PCL constructs, albeit 
a comprehensive remodeling of the cartilage had occurred. 
For HA/TCP, PU and collagen I scaffolds, more mature 
bone formation with rich vascularity and marrow stroma 
development could be observed. These data suggest that 
chondrogenic priming of MSCs in the presence of different 
scaffold materials allows the establishment of reliable 
templates for generating functional endochondral bone 
tissue in vivo without using osteoinductive growth factors. 
The morphology and maturity of bone formation can be 
dictated by the scaffold properties.
Keywords: Bone regeneration, scaffold, mesenchymal 
stem cells, endochondral bone formation, subcutaneous 
implantation.
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Introduction
Since the introduction of tissue engineering concept, cell-
based bone regeneration strategies have received much 
attention (Langer and Vacanti, 1993; Meijer et al., 2007). 
The conventional approach in this field is to combine 
mesenchymal stem cells (MSCs) with biomaterials/
scaffolds followed by directing MSCs towards the bone 
lineage in vitro, which resembles intramembranous 
ossification (Caplan, 2005). However, the clinical 
translation of this approach so far has been unsatisfactory 
(Meijer et al., 2007). Lack of sufficient vascular supply, 
resulting in immediate cell death after implantation, is 
generally thought to be the cause of failure of the cell-
scaffold constructs in patients (Farrell et al., 2009).
 Recently, in the context of skeletal tissue development 
and repair, endochondral ossification has inspired a 
new approach to regenerate bones (Farrell et al., 2006; 
Janicki et al., 2010; Farrell et al., 2011). In this approach, 
MSCs seeded on scaffolds are first primed towards the 
chondrogenic lineage in vitro before implantation. These 
cartilage intermediates work as osteoinductive templates 
and transform into bone tissue in vivo (Jukes et al., 2008; 
Farrell et al., 2009; Scotti et al., 2013). The recent findings 
suggest that this endochondral ossification approach may 
be more successful compared to the intramembranous 
route. It is known that cartilage is well adapted to limited 
nutrition supply and hypoxic conditions (Mackie et al., 
2008). In addition, during the hypertrophic stage of 
the endochondral process, the chondrocytes produce 
substantial amount of vascular endothelial growth factor 
(VEGF), which plays a critical role in the establishment of 
vessel in-growth and extracellular matrix remodeling (Dai 
and Rabie, 2007). The morphogenetic signals from the 
chondrocytes also promote the osteogenic differentiation 
of local MSCs (Gerstenfeld et al., 2002; Hwang et al., 
2007). Hence, the endochondral bone tissue engineering 
route may allow for a longer temporal window for 
vascularization and has potential for engineering larger 
bone constructs.
 For the final clinical application of such a strategy, an 
appropriate scaffold is an indispensable element, which 
provides a three-dimensional (3D) environment as well 
as the mechanical support for the cells (Hutmacher et 
al., 2007). Regarding endochondral bone formation, it 
is a unique transition process from chondrogenesis to 
osteogenesis and involves several instances of extracellular 
matrix (ECM) degradation and remodeling. Thus, the 
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scaffolds for endochondral bone tissue engineering 
should be able to support cells in differentiating into 
chondrogenic lineage in vitro and meanwhile, also promote 
the calcification of a cartilage template into bone after 
in vivo implantation. Cartilage matrix consists of highly 
hydrated proteoglycan embedded into a type II collagen 
network. Based on the previous findings, hydrogels made 
from natural or synthetic polymers have shown to support 
the phenotype of chondrocyte (Spiller et al., 2011). On the 
other hand, bone tissue is more rigid than cartilage and 
impregnated mainly with hydroxyapatite (HA) and type I 
collagen. Among the candidate scaffold materials, porous 
bioceramics and degradable polymers are widely studied 
because of their mechanical competence and structural 
feasibility for fluid perfusion and vessel in-growth. Apart 
from the aforementioned, nanofibrous scaffolds made 
by electrospinning have also gained research interest in 
both cartilage and bone tissue engineering due to their 
morphological resemblance to the natural extracellular 
matrix (Pham et al., 2006; Sill and von Recum, 2008).
 In this study, we aimed at testing the performance 
of different 3D scaffolds for endochondral bone tissue 
engineering. To that end, four representative scaffolds 
(ceramic- or polymer-based) with distinct structural 
features were selected from the aforementioned materials, 
including porous hydroxyapatite/tricalcium phosphate 
(HA/TCP), porous polyurethane (PU), fibrous poly(lactic-
co-glycolic acid) (PLGA) electrospun scaffolds and 
collagen I hydrogel. Rat primary MSCs were seeded 
on these scaffolds and chondrogenically primed for 4 
weeks in vitro. The formation of cartilage templates was 
characterized by matrix quantification and gene analysis. 
After 4 weeks of in vitro culture, the chondrogenically 
primed cell-scaffold constructs were subcutaneously 
implanted in rats for 8 weeks and then the spatial pattern 
of bone formation and cartilage remains were assessed 
in each construct in terms of quality and quantity by 
immunohistological stainings and polarized microscopy.
Materials and Methods
Scaffold preparation
Four different types of scaffold materials were used in 
this study:
• Porous sintered HA/TCP composite (CAM bioceramics, 
Leiden, the Netherlands) was obtained in a cubic shape 
of 3 × 3 × 3 mm3 and consisted of HA and TCP with 
a 75/25 ratio. The volumetric porosity was 75 % 
(provided by the manufacturer). HA/TCP (Fig. 1a) 
showed a macro-porous structure with pore sizes 
ranging from 300-800 µm.
• Porous PU scaffold was fabricated by in situ 
polymerization and simultaneous foaming as 
previously described (Liu et al., 2009; Wang et 
al., 2009). The scaffold displayed a similar porous 
structure to HA/TCP (Fig. 1b) and the porosity is 80 % 
(Wang et al., 2009).
• Fibrous PLGA (Purasorb® PDLG 8531, Purac 
Biomaterials BV, Gorinchem, the Netherlands) 
combined with poly(ε-caprolactone) (PCL, LACTEL® 
Absorbable Polymers, DURECT Corporation, 
Cupertino, CA, USA) electrospun scaffold was made 
by a wet-electrospinning technique (Esprayer ES-
2000S, Fuence, Tokyo, Japan) as previously described 
(Yang et al., 2013). The obtained scaffold (Fig. 1c) 
displayed an uncompressed structure with an average 
fiber diameter of 1.98 ± 0.51 µm and a porosity of 
99 % (Yang et al., 2013).
• Collagen hydrogel was prepared from type I collagen 
(rat tail) (BD Biosciences, Bedford, MA, USA) with 
the final concentration at 6 mg/mL according to the 
manufacturer’s instructions.
 Both PLGA/PCL and PU scaffolds were punched into a 
disk shape for the following experiments with a diameter of 
6 mm and a thickness of 2 mm. Collagen I gel was shaped 
to the same size during the cell seeding procedure. The 
morphology of the scaffolds was observed by scanning 
electron microscopy (SEM; JEOL6340F, Tokyo, Japan) 
after being sputter-coated with gold-platinum.
Cell isolation, seeding and culture
MSCs were isolated from 6-week-old male Fischer rats 
(12 rats in total) (Charles River; www.criver.com), after 
the approval from Radboud University Nijmegen Animal 
Ethics Committee (Approval no: RU-DEC 2011-142). 
Briefly, two femora of each rat were removed and the 
epiphyses were cut off. Rat MSCs were flushed out of 
the remaining diaphyses using the proliferation medium 
through an 18G needle (BD Microlance, Drogheda, 
Fig. 1. SEM micrographs of HA/TCP (a), PU (b) and PLGA/PCL (c) scaffolds. (Scale bar in a and b: 100 µm; c: 10 µm) 
(A micrograph of collagen I scaffold is not shown because the structure could not be preserved after freeze-drying.).
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Ireland). The proliferation medium consisted of alpha 
Minimal Essential Medium (αMEM; Gibco, Grand Island, 
NY, USA) supplemented with 10 % fetal bovine serum 
(FBS; Sigma-Aldrich, St. Louis, MO, USA), 100 U/mL 
penicillin, 100 μg/mL streptomycin (Gibco), 50 μg/mL 
l-ascorbic acid (Sigma-Aldrich) and 10 nM dexamethasone 
(Sigma-Aldrich). The flush-out was cultured for 2 days 
in a humidified incubator (37 °C, 5 % CO2), after which 
the medium was refreshed to remove non-adherent cells. 
The cells were cultured for an additional 3 days followed 
by detachment using trypsin/EDTA (0.25 % w/v trypsin, 
0.02 % w/v EDTA; Sigma-Aldrich) and counted.
 Before cell seeding, the scaffolds were sterilized either 
by autoclave (PU and HA/TCP) or incubation in 70 % 
ethanol for 2 h (PLGA/PCL) then washed with phosphate 
buffered saline (PBS). Subsequently, all scaffolds were 
soaked in the proliferation medium overnight. During cell 
loading, the scaffolds were incubated in the cell suspension 
with a concentration of 1 × 106 cells/mL (4 scaffolds 
per 1 mL of cell suspension) and gently rotated for 3 h. 
Successively, the scaffolds were placed in non-adherent 
tissue culture plates and the unattached cells from the 
suspension were collected, centrifuged and reseeded onto 
the scaffolds to ensure a high cell loading efficiency. For 
collagen I scaffolds, the gel was made aseptically according 
to the manufacturer’s instructions, mixed with cells, and set 
in cell culture inserts (ThinCert™ for 24-well plate, Greiner 
Bio-One, Frickenhausen, Germany). A concentration of 
250,000 cells per insert (with 120 µL gel) was used to 
obtain a disc shaped cell/collagen gel construct with a 
diameter of 6 mm and a thickness of 2 mm.
 All cell-scaffold constructs were cultured for 1 week 
in the proliferation medium. Thereafter, the medium was 
changed to the chondrogenic medium, consisting of high-
glucose DMEM (Gibco), 1 % FBS, 100 U/mL penicillin, 
100 μg/mL streptomycin, 50 μg/mL l-ascorbic acid, 
100 mM of sodium pyruvate (Gibco), 40 μg/mL l-proline 
(Sigma-Aldrich), 1:100 insulin-transferrin-selenium 
(ITS; BD Biosciences, Bedford, MA, USA), 100 nM 
dexamethasone, 10 ng/mL of transforming growth factor 
beta-2 (TGF-β2; R&D Systems, Minneapolis, MN, USA) 
and 100 ng/mL bone morphogenetic protein 2 (BMP-2; 
BD Biosciences). The constructs were cultured for 4 weeks 
and the medium was refreshed twice a week. Afterwards 
the samples were divided into two groups, one for in vitro 
characterization and the other for in vivo implantation.
In vitro tests
GAG content
The amount of GAG in each sample was detected by a 
sulfated glycosaminoglycan (sGAG) assay (n = 3). After 
being washed twice in PBS, all samples were digested in 
proteinase K solution (1 mg/mL proteinase K in 50 mM 
Tris with 1 mM EDTA, 1 mM iodoacetamide, and 10 μg/
mL pepstatin A) (all reagents from Sigma-Aldrich) for 
20 h at 56 °C. The GAG content was determined by using 
dimethylmethylene blue (Polysciences, Warrington, 
PA, USA), with chondroitin sulfate (Sigma-Aldrich) 
as standard control. Measurements of absorption were 
performed at 530 nm and 570 nm using an ELISA reader 
(Bio-Tek Instruments, Winooski, VT, USA). The results 
were calculated according to the previously described 
method (Farndale et al., 1986). For each sample, the 
GAG content was normalized by the amount of DNA as 
described under the subheading “DNA content” below.
DNA content
To evaluate the seeding efficiency on each type of scaffolds 
and the cell number before the implantation, DNA content 
of the seeded cells was measured after 24 h of seeding 
and 28 days of chondrogenic differentiation, respectively. 
PicoGreen assay (Quant-iT™ PicoGreen® dsDNA kit, 
Invitrogen/Life Technologies, Carlsbad, CA, USA) was 
performed using the same cell extract solution as treated for 
the GAG assay. A DNA standard curve was used to quantify 
the amount of DNA in each sample and the results were 
measured using a fluorescence microplate reader (Bio-Tek 
Instruments) with an excitation wavelength at 485 nm and 
an emission wavelength at 530 nm.
RNA extraction and qPCR analysis
Total RNA was extracted using Trizol method after 4 weeks 
of chondrogenic culture (n = 4). Briefly, scaffolds with cells 
were washed with PBS and cut into small pieces before 
adding 1 mL of Trizol (Invitrogen). The cell extract was 
collected, mixed with chloroform and centrifuged. Only the 
upper aqueous phase was collected and mixed with equal 
amount of isopropanol. After 10 min of incubation at room 
temperature, the mixture was centrifuged and washed twice 
with 75 % alcohol. Thereafter, the obtained RNA pellet was 
dissolved in RNase free water and the RNA concentration 
was measured with spectrophotometer (NanoDrop 2000, 
Thermo Scientific, Wilmington, DE, USA).
 First strand cDNA was reverse transcribed from RNA 
using the SuperScript® First-Strand Synthesis System kit 
(Invitrogen). Afterwards, cDNA was further amplified 
and the expression of specific genes was quantified using 
IQ SYBR Green Supermix PCR kit (BioRad, Hemel 
Hempstead, UK) in a real-time PCR (BioRaD, CFX96™ 
real-time system) (n = 4). Chondrogenic differentiation 
related gene markers were evaluated, including collagen 
type II (Col2α1), collagen type X (Col10α1), aggrecan 
Table 1. Primer sequences used for qPCR.
Forward (5’ → 3’) Reverse (5’ → 3’)
Col2α1
Col10α1
Acan
Vegfa
Gapdh
GACGCCACGCTCAAGTCGCT
GGGCCCTATTGGACCACCAGGTA
CATTCGCACGGGAGCAGCCA
ACTCATCAGCCAGGGAGTCT
CGATGCTGGCGCTGAGTAC
CGCTGGGTTGGGGTAGACGC
CCGGCATGCCTGTTACCCCC
TGGGGTCCGTGGGCTCACAA
GGGAGTGAAGGAGCAACCTC
CGTTCAGCTCAGGGATGACC
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(Acan), and VEGF (Vegfa) (Table 1). The expression levels 
were analyzed and compared to the housekeeping gene 
glyceraldehyde 3-phosphate dehydrogenase (Gapdh). The 
specificity of the primers was confirmed separately before 
the real-time PCR reaction. The expression of the tested 
genes was calculated using the 2-∆∆Ct method (Livak and 
Schmittgen, 2001) using HA/TCP as the reference group.
Histological analysis
All the samples were fixed in 10 % phosphate buffered 
formalin for 1 h before embedding. The in vitro PLGA/
PCL and collagen I scaffolds were embedded in paraffin 
(n = 3). The microtome sections with 6 μm of thickness 
were stained with 0.4 % thionin (Sigma-Aldrich) after 
deparaffinization in xylene and rehydration through graded 
ethanol. Simultaneously, HA/TCP and PU scaffolds were 
embedded in methylmetacrylate (MMA, L.T.I., Bilthoven, 
The Netherlands) because of their rigid character. The 
samples were sectioned to 15 μm using a microtome 
equipped with diamond blade (Leica SP1600, Leica 
Microsystems, Wetzlar, Germany) and then stained with 
0.4 % thionin solution.
In vivo implantation
After 4 weeks of in vitro culture, the cell-scaffold constructs 
were implanted subcutaneously in ten 8-week-old male 
nude rats (Crl:NIH-Foxn1rnu, Charles River). The protocol 
was approved by the Animal Ethical Committee of the 
Radboud University Nijmegen Medical Center (Approval 
no: RU-DEC 2011-142) and the national guidelines for the 
care and use of laboratory animals were applied. All rats 
received analgesic before and after the surgery. The surgical 
operations were performed under general inhalation 
anesthesia with a combination of isoflurane, nitrous 
oxide, and oxygen. The back of the rats was shaved and 
disinfected with povidone-iodine. Subsequently, four small 
longitudinal incisions were made. Lateral to each incision, 
a subcutaneous pocket was created. Each rat received a 
cell-scaffold construct from each of the four materials and 
the constructs were randomized. After placing the samples, 
the skin was closed using staples. After 8 weeks, the rats 
were euthanized by CO2-suffocation for sample collection.
Histological analysis of the in vivo samples
All in vivo samples were fixed in 10 % phosphate buffered 
formalin for 30 h and dehydrated through graded ethanol 
before embedding either in MMA or paraffin.
 MMA embedded samples (n = 5) were sectioned to 
15 μm using a microtome with diamond blade (Leica 
SP1600, Leica Microsystems) and then stained with 
methylene blue and basic fuchsin (both reagents from 
Merck, Darmstadt, Germany).
 Prior to paraffin embedding, the fixed samples (n = 5) 
were decalcified by 10 % EDTA and the decalcification 
process was monitored using X-ray. 5 μm-thick sections 
were made from each sample and used for hematoxylin/
eosin (HE), collagen II and tartrate-resistant acid 
phosphatase (TRAP) staining. For collagen II staining, 
sections were treated with 0.1 % pronase and 1 % 
hyaluronidase for antigen retrieval (both from Sigma-
Aldrich). Afterwards the sections were incubated for 1 h at 
room temperature with mouse monoclonal antibody against 
collagen type II (II-II6B3 antibody, 1:100; Developmental 
Studies Hybridoma Bank, Iowa City, IA, USA) linked 
with a biotin-labeled secondary antibody (1:500, Jackson 
Immuno Research, Newmarket, England). Then alkaline 
phosphatase-conjugated streptavidin (1:50, Biogenex HK-
321-UK) was used as the third antibody and the activity 
was visualized by using a new fuchsin substrate (Sigma-
Aldrich). An isotype immuno-globulin G1 monoclonal 
antibody was used as negative control. Counterstaining 
was performed with Gill’s hematoxylin (Sigma-Aldrich). 
For TRAP staining, sections were first incubated in Tris/
MgCl2-buffer for 1 h. Afterwards they were stained with 
acid phosphatase substrate solution at 37 °C for 30 min, 
which contained Naphthol AS-BI phosphate, sodium 
nitrite, N,N-dimethylformamide, potassium sodium tartrate 
and pararosaniline (all reagents from Sigma-Aldrich).
Polarized light microscopy
The in vivo MMA cross-sections were observed under 
polarized light using a light microscope (DM RBE Leica, 
Bensheim, Germany) in which the polarizer and analyzer 
were fixed perpendicularly to each other (cross-polarized 
light).
Statistical analysis
The data were analyzed using one-way ANOVA followed 
by Tukey’s Multiple Comparison Test (GraphPad Prism 
5, GraphPad Software, San Diego, CA, USA). Results 
are reported as mean values and standard deviation. 
Differences were considered statistically significant at 
p < 0.05.
Results
Cell seeding efficiency
After 24 h of cell seeding, the DNA content of the seeded 
cells on each group was measured to assess the seeding 
efficiency (Fig. 2a). The highest cell number was found 
on collagen I group, as all of the cells were encapsulated 
in the gel during cell seeding. A comparable amount of 
cells was detected on PU and PLGA/PCL scaffolds, which 
was around 65 % of the total cell number seeded onto 
the scaffolds. In comparison, the lowest cell number was 
shown on HA/TCP scaffolds, with the seeding efficiency 
of around 25 %.
DNA and GAG content pre-implantation
After 1 week of proliferation and 4 weeks of chondrogenic 
differentiation in vitro, comparable amounts of DNA could 
be found in HA/TCP, PLGA/PCL and collagen I scaffolds, 
which was significantly higher than that on the PU scaffolds 
as shown in Fig. 2b. Likewise, the normalized GAG content 
on the aforementioned three scaffolds was also comparable, 
but the PLGA/PCL constructs showed significantly higher 
GAG/DNA ratios than the PU samples (Fig. 2c).
Expression of chondrogenic genes pre-implantation
After 4 weeks of chondrogenic differentiation in vitro, a 
2-fold higher level of aggrecan expression was observed 
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for the HA/TCP group compared to the collagen I group, 
while there was no difference detected among the HA/TCP, 
PU and PLGA/PCL groups (Fig. 3a). Similar results were 
also found for VEGF expression where the HA/TCP group 
showed a significantly higher level of VEGF compared 
to the collagen I group (Fig. 3d). For collagen II gene 
expression, all groups showed a similar level (Fig. 3b). In 
contrast, a significantly higher expression of collagen X 
was detected for the PLGA/PCL groups (Fig. 3c).
Histological evaluation pre-implantation
To visualize the cartilage matrix deposition in the scaffolds, 
histological sections were made and stained with thionin 
after 4 weeks of chondrogenic culture. For both HA/TCP 
Fig. 2. DNA (a and b) and GAG (c) content on different scaffolds. DNA content after 24 h of seeding (a) was measured 
to evaluate the seeding efficiency. GAG content (c) was measured after 4 weeks of chondrogenic priming to assess 
the cartilage formation and normalized by the amount of DNA (b). ** indicates a statistically significant difference 
at p ＜ 0.01; error bars represent standard deviation (n = 3).
Fig. 3. Gene expression of aggrecan (a), collagen II (b), collagen X (c) and VEGF (d) after in vitro chondrogenic 
priming. The gene expression level of the cells seeded on HA/TCP scaffold was used for normalization. * indicates 
a statistically significant difference at p ＜ 0.05; ** indicates a statistically significant difference at p ＜ 0.01; error 
bars represent standard deviation (n = 4). The dashed red line indicates the gene expression level of the reference 
group (HA/TCP).
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Fig. 4. In vitro chondrogenic differatiation. The cartilage matrix deposition (stained purple) in the scaffolds was 
visualized by thionin staining after 4 weeks of in vitro culture. On HA/TCP (a and e) and PU (b and f), the cartilage 
matrix was formed in the pores of the scaffolds. The cells exhibited typical chondrocyte-like morphology and 
hypertrophy could be observed, whereby the lacunae of the cells were enlarged and the matrix was reduced (e and 
f). The shrinkage of the PLGA/PCL (c and g) and collagen I (d and h) scaffolds during the histological processing 
compromised the morphology of the cells. However, obvious cartilage matrix deposition was displayed in both 
scaffolds and a homogeneous distribution of cells could be observed. (S: scaffolds).
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and PU, as shown in Fig. 4a and b, the cartilage matrix 
was formed in the pores of the scaffolds and stained purple. 
The cells had a rounded or polygonal shape and formed 
isogenous groups, exhibiting typical chondrocyte-like 
morphology (Fig. 4e and f). Furthermore, the majority of 
the cells had reached the hypertrophic stage whereby the 
lacunae were enlarged and the matrix was reduced.
 The shrinkage of the fibrous scaffold during the 
histological processing compromised the morphology of 
the cells on PLGA/PCL. Nevertheless, a substantial GAG 
content was displayed in the scaffolds stained strongly in 
purple, representing the cartilage matrix (Fig. 4c). The 
PLGA/PCL fibers were embedded within the matrix and 
a homogeneous distribution of cells could be observed 
throughout the fibrous structure (Fig. 4g). Similarly, the 
collagen I scaffolds also showed cartilage matrix deposition 
although here the shrinkage was less, while the total 
amount appeared to be lower than PLGA/PCL scaffolds. 
(Fig. 4d and h).
Histological analysis of in vivo bone formation
All animals recovered uneventfully from the surgical 
procedure and remained in good health. No signs of wound 
complications were observed post-operatively. After 8 
weeks of implantation, all samples were retrieved and an 
obvious increase in hardness of PLGA/PCL, collagen I and 
PU scaffolds could be sensed by hand. Macroscopic signs 
of inflammation or adverse tissue responses were absent 
for all retrieved samples.
 To evaluate the bone forming quality and quantity, 
different histological staining methods were used for 
either MMA (Fig. 5) or paraffin (Fig. 6) embedded 
samples. Bone formation was found in all HA/TCP, PU 
and collagen I constructs, and nine (out of ten) PLGA/
PCL scaffolds. For the bone-formed samples within each 
group, the bone forming quality was similar as observed 
from the histological stainings. Due to the deformation of 
PU and PLGA/PCL scaffolds during the tissue processing 
procedures, the original material area could not be defined 
to quantify the ratio of bone formation within the scaffolds.
HA/TCP scaffolds
As shown in Fig. 5a, substantial bone formation was 
present at both the periphery and inside of the scaffolds. 
Within the macro-pores, the structure of a marrow cavity 
filled with hematopoietic cells and adipocytes could be 
observed, surrounded by concentric deposition of bone 
matrix. Moreover, plenty of blood vessels penetrated 
randomly in these bone forming areas (Fig. 6a and b). 
Osteocytes were embedded in the bone matrix, showing 
relatively round shapes. Collagen II staining confirmed that 
only a small amount of cartilage (stained pink) remained, 
which was occasionally found in the small pores of a 
few samples where cells kept the chondrocyte like shape 
without breaking down the surrounding matrix (Fig. 6c).
PU scaffolds
PU scaffolds underwent deformation during the histological 
processing. Bone formation was observed in the scaffolds, 
Fig. 5. Overview of in vivo bone formation. MMA sections of HA/TCP (a), PU (b), PLGA/PCL (c) and Collagen 
I (d) samples after 8 weeks of implantation were stained with methylene blue and basic fuchsin. Bone formation 
(stained red) displays in different spatial arrangements on each type of scaffold.
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especially in the pores located in the peripheral area (Fig. 
5b). Surrounded by the bone tissue, a marrow-like structure 
or a loosely organized fibrous tissue-like structure was 
detected in these pores together with blood vessel in-
growth (Fig. 6d and e). The amount of bone formation in 
the central pores was relatively low compared to HA/TCP 
scaffolds. Chondrocytes or cartilage-like structure could 
not be seen at this time point. Collagen II staining revealed 
a slight amount of tissue stained light pink, indicating that 
the replacement of in vitro cartilage with bone tissue was 
nearly completed (Fig. 6f).
PLGA/PCL scaffolds
Extensive cartilage remodeling could be observed inside of 
PLGA/PCL scaffolds. Islets of bone tissue were scattered 
amongst the remnants of scaffold material, indicating the 
Fig. 6. Histological analysis of in vivo bone formation on scaffolds. After 8 weeks of implantation, HE (left and 
middle column) staining showed that the bone formation on HA/TCP (a), PU (d) and Collagen I (j) scaffolds was 
associated with bone marrow development while on a PLGA/PCL scaffold (g) the bone tissue displayed a woven 
bone-like structure without concentrically organized structure and marrow formation. In the magnified images of the 
black squared box (middle column), osteocytes were embedded in the bone matrix and blood vessels penetrated in the 
bone forming areas on all scaffolds. Collagen II staining (right column) confirmed significant remaining of cartilage 
matrix (red color) on PLGA/PCL (i) while the remodeling of in vitro cartilage into bone tissue was nearly completed 
on HA/TCP (c), PU (f) and Collagen I (l) scaffolds. The black arrow indicates a blood vessel and the arrow head in the 
white magnified box indicates embedded electrospun fibers. (B: bone; BM: bone marrow; S: scaffold; C: cartilage).
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Fig. 7. Histological analysis of in vivo osteoclast activity. After 8 weeks of in vivo implantation, the activity of 
osteoclasts (stained red) was visualized by TRAP staining. For HA/TCP, PU and collagen I scaffolds, osteoclast activity 
was positive (a, b and d) which scattered along the edge of bone matrix (e, f and h). In comparison, an extensive 
level of osteoclast activity was observed throughout the PLGA/PCL scaffolds (c), which was not only located along 
the edge of new bone formation, but also present in the middle area of the bone/cartilage mixed matrix (g).
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Fig. 8. Observation of 
in vivo bone formation 
under polarized light. 
Newly formed bone 
tissue in each scaffold 
(embedded in MMA) was 
stained with methylene 
blue / basic fuchsin (a-d) 
and examined under the 
polarized light (e-h). The 
bone tissue was stained 
red (a-d) and the collagen 
bundles which were 
oriented transversely 
to the direction of the 
light propagation were 
distinguished in bright 
pink under the polarized 
light (e-h). In HA/TCP 
(a and e), PU (b and f) 
and collagen I (d and h) 
scaffolds, a concentric 
and paral lel  pat tern 
of the collagen fibril 
arrangement could be 
observed partially in the 
bone forming regions. 
For PLGA/PCL scaffolds 
(c and g), the bone matrix 
displayed an isotropic 
organization. (Scale bar: 
50 µm).
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onset of the newly formed bone. Concentrically organized 
bone tissue with marrow cavity structures could not be 
observed (Fig. 5c). HE staining revealed that the bone 
tissue displayed a woven bone like structure with vascular 
invasion. A large number of immature osteocytes were 
embedded in the matrix and randomly arranged (Fig. 6g 
and h). Interestingly, the remaining PLGA/PCL fibers of 
the scaffolds were also embedded in the matrix as indicated 
in Fig. 6h. Furthermore, the collagen II staining (Fig. 6i) 
confirmed the existence of the remaining cartilage matrix 
(red color). Compared to the PLGA/PCL constructs before 
implantation (Fig. 3c), the in vivo samples contained 
considerably reduced amounts of cartilage matrix. 
However, the newly formed bone still resembled a mixture 
of cartilage and calcified cartilage tissue or bone.
Collagen scaffolds
Bone formation with marrow development was observed in 
collagen I gel. An intact bone layer was displayed along the 
fibrous capsule. A trabecular bone-like structure, together 
with a great number of adipocytes and hematopoietic cells, 
was distributed in the middle part (Fig. 5d). Blood vessels 
penetrated in the stroma and were also present inside 
the bone tissue (Fig. 6j and k). There was no remaining 
cartilage matrix visualized by a collagen II staining, which 
indicated the complete replacement of in vitro cartilage by 
new bone tissue (Fig. 6l).
Histological analysis of osteoclast activity
The activity of osteoclasts was visualized by TRAP 
staining. After 8 weeks of in vivo implantation, osteoclast 
activity was positive on HA/TCP, PU and collagen I 
scaffolds (Fig. 7), which scattered along the edges of bone 
matrix. In comparison, an extensive level of osteoclast 
activity was observed throughout the PLGA/PCL scaffolds, 
which was not only located along the edges of new bone 
formation, but also present in the central area of the bone/
cartilage mixed matrix.
Polarized light observation
The collagen bundle arrangement of the newly formed 
bone tissue on each scaffold was examined under polarized 
light on the basis of its birefringent character. As shown 
in Fig. 8, the collagen bundles within the bone forming 
areas which were oriented transversely to the direction of 
the light propagation were visualized in bright pink under 
polarized light. In HA/TCP (Fig. 8a and e), PU (Fig. 8b 
and f) and collagen I scaffolds (Fig. 8d and h), a parallel 
pattern of collagen fibril arrangement could be partially 
observed in the bone forming regions, indicating the initial 
organization of the lamellar bone. However, in the PLGA/
PCL scaffolds (Fig. 8c and g), the bone matrix displayed a 
random spatial organization, as shown by an isotropic and 
un-polarized structure.
Discussion
An appropriate scaffold material is an essential component 
in bone tissue engineering as it regulates the cellular 
behaviors, such as cell proliferation and differentiation, 
on both chondrogenic and osteogenic pathways (Kuboki 
et al., 2001; Mahmoudifar and Doran, 2012). In this study, 
we aimed to evaluate and compare the efficacy, using 
endochondral ossification, of four scaffolds for bone tissue 
regeneration. These were, porous HA/TCP composites, 
porous PU foam, PLGA/PCL electrospun fibers and 
collagen I gel.
 Our results showed different cell seeding efficiencies on 
the tested scaffolds due to their varied structural features, 
among which the HA/TCP scaffolds had the lowest initial 
cell number. Nevertheless, 1-week culture in proliferation 
medium ensured a comparable amount of cells present 
on these scaffolds prior to the implantation, as the low-
serum chondrogenic culture condition would principally 
not stimulate the cell proliferation. The results also 
indicated that, all of the selected scaffolds supported cell 
growth and proliferation. Similarly, comparable cartilage 
formation in the scaffolds was also shown before the in vivo 
implantation. However, cells cultured on the PLGA/PCL 
scaffolds expressed a significantly higher level of collagen 
X compared to those on the other types of scaffolds. In vivo 
results revealed that 8 weeks of implantation was sufficient 
to ossify nearly the complete constructs of HA/TCP, PU 
and collagen constructs and form a hematopoietic bone 
marrow, while the bone formation on PLGA/PCL scaffolds 
displayed an immature structure with a random spatial 
organization of collagen bundle and obvious cartilage 
remaining. Furthermore, an extensive level of osteoclast 
activity present throughout the PLGA/PCL scaffold also 
demonstrated a highly active cartilage and bone remodeling 
in PLGA/PCL compared to the other three scaffolds. 
These results indicated that, although the cells on PLGA/
PCL might have an earlier hypertrophic stage in vitro, the 
cartilage remodeling and vessel invasion in PLGA/PCL 
was less efficient in vivo compared to the other scaffolds.
 Hypertrophic cartilage remodeling is a critical process 
to initialize the successive endochondral bone formation 
and such progression is closely related to the reciprocal 
interaction between the cells and natural ECM (Benders et 
al., 2013). Cellular products, e.g., proteinases and VEGF, 
modify the type X collagen-rich ECM and promote vessel 
formation; ECM also releases sequestered growth factors 
and cytokines to regulate the endochondral commitment 
of the cells (Kronenberg, 2003). Hypertrophic cartilage 
remodeling usually couples the expression of VEGF 
(Gerber et al., 1999). Surprisingly, a significantly higher 
level of collagen X expression on PLGA/PCL scaffolds did 
not result in an elevated VEGF expression of the cells. This 
may consequently lead to the formation of less mature bone 
in PLGA/PCL scaffolds compared to the other scaffolds. 
Moreover, a comparable endochondral bone formation 
was observed on HA/TCP and collagen I gel, although a 
significant difference of VEGF expression was shown for 
these two scaffolds prior to the implantation. Therefore, 
apart from the natural ECM, the scaffolds, acting as a 
synthetic ECM, also played an essential role in directing 
the cells to form endochondral bone in vivo.
 Noticeably, our data demonstrated that the structure 
and maturity of the endochondral bone is material/
scaffold dependent. Among various scaffold properties, 
geometry and composition played important roles. In 
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vivo, higher percentage of porosity allows for better cell 
recruitment and vascularization, which leads to improved 
osteogenesis (Karageorgiou and Kaplan, 2005). On top 
of that, scaffold pore size can dictate the structure and 
the mode of the newly formed bone (intramembranous or 
endochondral) (Kuboki et al., 2001). In an in vivo study 
of BMP-2 induced osteogenesis and chondrogenesis 
using honey-comb-shaped HA scaffolds, small diameter 
‘tunnels’ (90-120 µm) favored chondrogenesis followed 
by osteogenesis, while large diameter ‘tunnels’ (350 µm) 
favored intramembranous bone formation (Jin et al., 
2000; Kuboki et al., 2001). Regarding the bone structure, 
increased trabecular formation appeared to be supported 
when the scaffolds have smaller pores (Sundelacruz and 
Kaplan, 2009). Similarly, in our study, more lamellar-like 
bone structure with bone marrow formation was generated 
on HA/TCP and PU scaffolds compared to PLGA/PCL. 
This might be related to the larger pore size of HA/TCP 
and PU scaffolds, which can facilitate more oxygen and 
nutrient diffusion and allow easier vessel in-growth during 
cartilage/bone remodeling. In comparison, the small pore 
size of PLGA/PCL scaffolds might have created a hypoxic 
environment which favored the cartilage maintenance 
(Karageorgiou and Kaplan, 2005). Furthermore, the 
confined porous structure of HA/TCP and PU can 
concentrate collagen fibers within the pores and trigger 
their self-assembly, thereby forming the lamellar-like bone 
(Scaglione et al., 2012). Conversely, in fibrous PLGA/PCL 
scaffolds, new collagen fibers formed by the cells were 
distributed in a random manner, resulting mostly in woven 
bone (Scaglione et al., 2012). Thus, the specific design of 
the scaffold can drive the arrangement of collagen fibers 
and consequently target bone formation.
 Bone in-growth to the central part of the HA/TCP 
scaffold had a relatively higher volume compared to 
the PU scaffolds, even though HA/TCP scaffolds were 
a little thicker. The main reason for the difference of 
bone in-growth might be that, unlike PU, HA and TCP 
are osteoconductive (Chai et al., 2012; Nirmala et al., 
2010). This osteoconductive property can promote the 
attachment of bone-forming cells from the host as well 
as cell migration and vessel formation (Hutmacher et 
al., 2007). Both PU and HA/TCP are slowly degrading 
materials which were unlikely to degrade after 8 weeks of 
implantation (LeGeros, 2008; Liu et al., 2009). However, 
compared to PU scaffolds, HA/TCP could actively release 
calcium and phosphate ions which can influence the local 
ionic concentration to trigger and provide the source for the 
deposition of calcium in the cartilage matrix for subsequent 
remodeling (LeGeros, 2008). With respect to PLGA/PCL 
scaffolds and collagen I gel, the naturally derived collagen 
I component resembles the organic composition of natural 
bone and is considered more osteoconductive than the 
synthetic polymers, i.e., PLGA and PCL (Oliveira et al., 
2010), which also has contributed to the differences in 
bone formation between these two scaffolds.
 For in vivo bone generation, the origin of bone cells 
and the ossification type are closely related to the nature 
and commitment of the seeded cells. Previous results have 
suggested a tendency of MSCs to undergo endochondral 
ossification when implanted in vivo. Hartman et al. seeded 
rat MSCs onto porous HA/TCP scaffold to investigate 
ectopic bone formation using the intramembranous 
approach, while the onset of bone tissue was always 
surrounded by hypertrophic cartilage-like cells (Hartman 
et al., 2005). Tortelli et al. combined murine MSCs or 
mature osteoblasts with porous ceramic scaffolds and 
subsequently implanted them ectopically in mice (Tortelli 
et al., 2010). New vascularized bone was formed through 
the activation of the endochondral ossification process 
in the MSC-scaffold complex. Conversely, osteoblasts 
directly formed bone by an intramembranous ossification, 
without any signs of vascularization (Tortelli et al., 2010). 
The aforementioned results indicated that, activating 
MSCs toward an endochondral ossification route is 
presumably in line with their natural developmental 
pattern and provides significant advantages in generating 
vascularized bone tissue. Our results demonstrated the 
tendency of in vitro chondrogenically induced MSC to 
ossify in a non-chondrogenic environment in vivo, which 
is also consistent with some previous studies (Pelttari et 
al., 2006; Abrahamsson et al., 2010; Spiller et al., 2011). 
When combined with various scaffolds, scaled-up bone 
formation with the structure and functionality comparable 
to that of native bones could be achieved in vivo without 
the use of any osteoinductive growth factors, e.g., BMP-2, 
at the implant site. Among the tested scaffold materials, 
HA/TCP block and collagen I gel supported most mature 
bone formation within the entire constructs. Regarding 
the clinical applications, Collagen I gel is appealing for 
irregularly shaped defects and its fast degradation allows 
rapid turnover of the new bone tissue in the implantation 
site. HA/TCP scaffold is more suitable for the implantation 
in the load-bearing areas, which can provide initial 
structural stability. Nevertheless, considering the ceramic 
scaffolds are brittle, the mechanical property of HA/TCP 
needs to be further modified, for instance by incorporating 
polymeric components.
 Some limitations of our study have to be addressed: 
(i) the evaluation was only performed at one time point 
of 8 weeks after implantation, (ii) the scaffolds were of a 
relatively small size which might favor cell invasion and 
vascularization, (iii) the implantation was only performed 
in a subcutaneous environment where the mechanical 
stimuli are not involved, and (iv) due to the differences 
in composition and structure of the selected scaffolds, the 
specific parameters of a material scaffold that dominate the 
endochondral bone forming process could not be concluded 
from the current study. A more complete understanding will 
be obtained if all structural parameters of the scaffolds are 
kept constant and only the composition is varied, or vice 
versa. Further investigations are warranted to dynamically 
monitor the endochondral bone-forming process in an 
orthotopic implantation site. Furthermore, systematical 
investigations are also needed to address how this process 
is driven by the parameters of the supporting materials, so 
that more appropriate scaffolds can be selected and tailored 
to target large-scale bone regeneration.
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Conclusion
In this study, chondrogenic priming rat MSCs in the 
presence of different 3D scaffold materials followed by 
subcutaneous implantation allowed us to establish a reliable 
scaffold-based heterotopic model for endochondral bone 
formation. The bone quality and maturity was scaffold/
material-dependent. Eight weeks of implantation was not 
sufficient to ossify the entire PLGA/PCL constructs, while 
a comprehensive remodeling of the cartilage had occurred. 
HA/TCP, PU and collagen I scaffolds supported full 
bone formation with rich vascularity and marrow stroma 
development. This study revealed that bone could be 
generated heterotopically via the endochondral pathway in 
the absence of osteoinductive growth factors and scaffold 
properties could dictate the morphology and maturity of 
endochondral bone formation. Continued research in this 
direction would open the attractive possibility to target 
large-scale bone regeneration.
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Discussion with Reviewers
C. Scotti: As pointed out by the authors, the efficacy 
of this approach should be assessed with a model more 
challenging, especially for vascularization, e.g., a critically 
sized bone defect in larger animal. The clinical translation 
is hampered by a relatively long time of in vitro culture 
of human cells, with rising costs and regulatory burden. 
Moreover, four weeks of culture might be acceptable 
for planned surgeries (e.g., spinal fusion, limb length 
restoration), but not in case or of trauma-emergency 
surgery. Do authors have any comments on that?
Authors: We agree with the reviewer that the clinical 
translation will be hampered if a long time of in vitro 
culture is needed before the implantation. Considering the 
necessity of in vitro culture, endochondral bone formation 
approach is not suitable for the treatment of emergency 
cases. In this study, a 4-week in vitro chondrogenic priming 
time was chosen based on the previous published results 
(Farrell et al., 2011, text reference). However, it has to 
be noted that no consensus hitherto exists regarding the 
optimal length of the in vitro chondrogenic priming time. 
As a next step, we plan to investigate if similar or even 
better bone formation can be achieved using shortened in 
vitro culture time. Other approaches, such as using specific 
hormones or growth factors in culture, modulating oxygen 
tension and applying mechanical stimuli, might also be 
useful to speed up the in vitro chondrogenic differentiation 
process.
M. Peroglio: From a translational point of view, the cost 
of a four week in vitro culture prior to implantation would 
be high. What strategies could be used to reduce the in 
vitro culture time?
Authors: Several strategies might be used to reduce the 
in vitro culture time:
1. Adding soluble mediators in the culture medium, such 
as vitamin D3, retinoic acid, and β-glycerophosphate 
to speed up the process of chondrogenic hypertrophy 
(Gerstenfeld and Shapiro, 1996, additional reference; 
Farrell et al., 2009, text reference).
2. Modulating oxygen tension. Hypoxic condition was 
reported to stimulate the chondrogenic differentiation. 
An increase of the oxygen after the chondrogenic 
differentiation might further stimulate the commitment 
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to the endochondral route (Fragonas et al., 1998; 
Morita et al., 2007, additional references).
3. Applying mechanical stimuli, such as compressive 
and shear forces, to promote cartilage maturation 
(Sundaramurthy and Mao, 2006; Kreke et al., 2008, 
additional references).
M. D’este: In order to better assess the bone forming 
capacity of the 4 seeded scaffolds, please perform a 
histomorphometrical quantification of the bone. Please 
comment.
Authors: We agree that a better understanding of the bone 
forming capacity of the scaffolds will be obtained with 
histomorphometrical quantification results. Unfortunately, 
due to the obvious deformation of PU matrix and shrinkage 
of PLGA/PCL scaffolds during the tissue processing 
procedures, it was impossible to define the original material 
area for calculation of the bone formation ratio within the 
scaffolds. Therefore, we presented the qualitative data in 
this manuscript to compare the bone formation on each 
type of scaffold.
M. D’este: In order to better characterize the hypertrophic 
cartilage templates prior to implantation, please perform a 
ColX staining on all samples at the end of in vitro culture. 
This would help also in understanding the biologic effect 
of the higher ColX expression by the MSC seeded in the 
PLGA/PCL scaffolds.
Authors: Unfortunately, for the in vitro primed PU and 
HA/TCP scaffold, we could only embed them in MMA for 
successful sectioning. Therefore, collagen X staining could 
not be performed on these MMA-embedded scaffolds. 
To characterize the hypertrophic cartilage templates, we 
provide PCR results of collagen X expression in our study.
M. D’este: Considering the difficulties in translating 
effectively a tissue engineering strategy to the clinic, how 
to you envision a clinically compliant method based on 
endochondral ossification?
Authors: For the clinical translation, it is possible to isolate 
autologous or allogeneic stem cells from for instance 
bone marrow or adipose tissues. These cells would be 
seeded on an appropriate scaffold and cultured in the 
chondrogenic condition in vitro for a certain time period to 
create a cartilage template prior to the in vivo implantation. 
Considering the necessity of in vitro culture, endochondral 
bone formation approach is not suitable for the treatment 
of emergency cases. However, it is applicable for some 
planned surgeries, e.g., limb length restoration, spinal 
fusion surgery, dental implantation and plastic surgery.
M. Peroglio: What effect would have changes in the 
scaffold parameters (e.g., percentage of porosity, pore size, 
and shape) on the performance of the different scaffolds 
in vitro and in vivo?
Authors: The porosity and pore size of biomaterial 
scaffolds play a critical role in cellular behavior in vitro 
and in vivo. The effect of these morphological features on 
osteogenesis has been elaborated previously (Karageorgiou 
et al., 2005; text reference). Based on the literature and 
also the results from this study, the authors expect that 
macropore will promote the bone maturation in vivo 
during the endochondral approach, while micropore might 
favor the hypoxic condition that maintains the cartilage 
phenotype. Increased porosity and interconnectivity of the 
scaffold promoted the cell migration of the cells in vitro 
and the penetration of blood vessel into the implant in vivo. 
However, it also has to be noted that increasing porosity 
will diminish the mechanical property of the applied 
scaffolds. As the endochondral bone formation is a unique 
process, morphological features of the scaffolds need to be 
installed in a balance of supporting both chondrogenesis 
and osteogenesis. More systematic studies are warranted 
in this field to address how this process is driven by the 
parameters of the supporting materials, so that more 
appropriate scaffolds can be selected and tailored to target 
large-scale bone regeneration.
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